Einblicke
Resilient Companies Build Resilient Supply Chains
|
|
Resilience
|
• |
Mai 18, 2020
|
Resilient Companies Build Resilient Supply Chains
|
Mai 18, 2020
|
Resilient Companies Build Resilient Supply Chains
Resilient Companies Build Resilient Supply Chains |
|
The coronavirus pandemic appears to be accelerating the supply chain localization/diversification theme that we in the Emerging Markets Leaders team have been debating for some time. As we focus on structural forward-looking ideas, we seek to identify those firms acting to increase the resilience of their business model to inventory disruptions by diversifying their supply chain.
The companies invested in this theme are not only reducing their environmental footprint; they are also building competitive advantages. By diversifying and going local, they are reducing transport costs and hedging against future supply disruptions that might arise.
De-globalization has been part of the investment zeitgeist since the global financial crisis of 2008, with slowing trade flows and rising nationalism. As the supply chains come under pressure from the transportation and demand disruptions caused by the corona pandemic, we expect the diversification and localization to increase. In fact, we believe that this trend will likely gather momentum in future, along with a rising awareness of the threat of production disruptions and their potential for negative impacts on business.
Supply Chain Diversification Gathers Momentum
A recent Bank of America survey of 3,000 firms reported that companies in 10 out of 12 global industries have shifted, or plan to shift, at least part of their supply chains1. Similar intentions have been expressed by the companies invested by the Emerging Leaders Strategy. Against this backdrop, we believe that the chemical and technology sectors in particular will benefit as more firms shift away from China with India and Southeast Asian countries potentially becoming the beneficiaries. The reliance on China across pharmaceutical, technology and chemical sectors will likely lessen in the period ahead, and indeed, we see potential for massive change as supply chains are diversified.
In our view, the main question now is: How quickly will these supply chain changes take place? When the U.S.-China trade war started in 2017, some firms moved to Vietnam by setting up small ancillary capacities there. Many of the companies that had relocated had intended this to be a temporary solution to the ongoing trade tension between the U.S. and China, but these temporary moves have now become much larger permanent solutions. We have been monitoring the rate of change in the relocation process and find increasing anecdotal evidence of more firms, and not just American ones, announcing joint ventures with Southeast Asia- and India-based companies in the chemical and pharmaceutical sectors.
Case Study: A Global Leader in Benzene Chemical Based Products
One of our investment holdings is a play on the structural increase of India’s market share in the global chemical supply chain and the ongoing import substitution within the domestic market. It is a mid-teens topline and profit growth story, helped both by volume and mix improvement. The holding has compounded EBITDA growth of 16% CAGR over last 20 years and has maintained 16%+ ROIC. It has built a sustainable business by building “depth” in chemistry (continuous downstream integration) and “breadth” in customer base over the last 20 years.
Our investment in the holding is also a call on the execution skills of the promoter family along with the described global reallocation trend. There has been a successful transfer of management control to the second generation whom have demonstrated their capabilities by significantly expanding the firm’s products and diversifying clients over the last five years. We expect earnings will accelerate to the high teens in the second half of this year as the first half will see disruptions from the COVID-19 virus.
We believe that the company should deliver strong upside potential given its growth trajectory. Over the long term, we expect specialty chemicals to show double-digit growth for the next decade, driven by:
- Increasing share of exports from India due to supplier diversification by global majors and environment-related shutdowns in China. India’s share of the global chemicals trade has increased from 3.5% to 4.6% over the period 2015-20182.
- Increase in per capita consumption in India (20% of world average as the per capita consumption in India is US$23 versus global average of US$1002.
- Import substitution (45% share of imports)2.
This stock had initially sold off as the global chemical supply chains became disrupted due to the shutdown in Europe and India, which offered us an opportunity to increase the position size given our conviction on the theme and the company. Its structural story remains intact and the short-term disruption remains a function of how soon it, and its customers, can restart their plants. Moreover, the recent decline in oil prices should provide additional tailwind for the holding as it releases working capital previously tied up within the business.
Resilient Supply Chains Are the Key to Success
The chemical industry’s supply chain inefficiencies have been exposed by the COVID-19 crisis, and we believe that in the medium-term, the process of diversifying the supplier base away from China will accelerate, and Indian companies stand to become the biggest beneficiaries as their resilience to future supply chain shocks increases.
Risk Considerations
There is no assurance that a portfolio will achieve its investment objective. Portfolios are subject to market risk, which is the possibility that the market values of securities owned by the portfolio will decline and that the value of portfolio shares may therefore be less than what you paid for them. Market values can change daily due to economic and other events (e.g. natural disasters, health crises, terrorism, conflicts and social unrest) that affect markets, countries, companies or governments. It is difficult to predict the timing, duration, and potential adverse effects (e.g. portfolio liquidity) of events. Accordingly, you can lose money investing in this portfolio. Please be aware that this portfolio may be subject to certain additional risks. In general, equities securities’ values also fluctuate in response to activities specific to a company. Investments in foreign markets entail special risks such as currency, political, economic, market and liquidity risks. The risks of investing in emerging market countries are greater than the risks generally associated with investments in foreign developed countries. Stocks of small- and medium capitalization companies entail special risks, such as limited product lines, markets, and financial resources, and greater market volatility than securities of larger, more established companies. Derivative instruments can be illiquid, may disproportionately increase losses and may have a potentially large negative impact on the Portfolio’s performance. Illiquid securities may be more difficult to sell and value than publicly traded securities (liquidity risk). Non-diversified portfolios often invest in a more limited number of issuers. As such, changes in the financial condition or market value of a single issuer may cause greater volatility. Privately placed and restricted securities may be subject to resale restrictions as well as a lack of publicly available information, which will increase their illiquidity and could adversely affect the ability to value and sell them (liquidity risk).
Global Emerging Markets Team
